Free Trial
→ How this >10-cent coin is going to outperform Bitcoin (From True Market Insiders) (Ad) Free KNSA Stock Alerts

Kiniksa Pharmaceuticals (KNSA) SEC Filings & 10K Form

Kiniksa Pharmaceuticals logo
$20.49 +0.17 (+0.84%)
(As of 12/17/2024 ET)
Compare

Recent Kiniksa Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
12/16/2024
4:17 PM		Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:34 PM		Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
6:14 PM		Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:25 PM		Kiniksa Pharmaceuticals (Subject)
Ragosa Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
4:13 PM		Kiniksa Pharmaceuticals (Subject)
Megna Michael R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
4:50 PM		Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
3:32 PM		HHLR ADVISORS, LTD. (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
3:30 PM		Kiniksa Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G/A
11/06/2024
3:11 PM		Kiniksa Pharmaceuticals (Subject)
Patel Sanj K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
3:14 PM		Kiniksa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
6:31 AM		Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
3:11 PM		BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13G
10/17/2024
3:35 PM		Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:57 PM		Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
4:29 PM		BAKER BROS. ADVISORS LP (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13D/A
10/08/2024
4:08 PM		Boyd Meta Cantey (Reporting)
Kiniksa Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/08/2024
3:40 PM		Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:14 PM		667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kiniksa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:39 PM		Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
4:02 PM		Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:57 PM		Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:51 PM		Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:52 PM		Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:53 PM		Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:55 PM		Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:42 PM		Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
4:16 PM		Kiniksa Pharmaceuticals (Subject)
Paolini John F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
4:17 PM		Kiniksa Pharmaceuticals (Subject)
Moat Ross (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
3:36 PM		Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
4:17 PM		Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:31 PM		Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:32 PM		Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:33 PM		Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:10 PM		Kiniksa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2024
6:54 AM		Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/04/2024
11:15 PM		Kiniksa Pharmaceuticals (Filer)
Form EFFECT
07/04/2024
11:15 PM		Kiniksa Pharmaceuticals (Filer)
Form EFFECT
06/30/2024
11:15 PM		Kiniksa Pharmaceuticals (Filer)
Form EFFECT
06/28/2024
4:29 PM		Kiniksa Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/28/2024
4:30 PM		Kiniksa Pharmaceuticals (Filer)
Form 15-15D
06/28/2024
4:22 PM		Kiniksa Pharmaceuticals (Filer)
Form POS AM
Musk threatens Liberal’s fake “energy crisis” (Ad)

Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.

To get the full details on the fake “energy crisis” of America, watch this now
06/28/2024
4:22 PM		Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:23 PM		Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:23 PM		Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:24 PM		Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:24 PM		Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/28/2024
4:25 PM		Kiniksa Pharmaceuticals (Filer)
Form S-8 POS
06/27/2024
8:34 PM		Kiniksa Pharmaceuticals (Filer)
Form POS AM
06/25/2024
3:30 PM		Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:27 PM		Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
3:35 PM		Kiniksa Pharmaceuticals (Issuer)
Quart Barry D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:36 PM		Kiniksa Pharmaceuticals (Issuer)
Popovits Kimberly J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:37 PM		Kiniksa Pharmaceuticals (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:39 PM		Kiniksa Pharmaceuticals (Issuer)
Malley Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:40 PM		Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:41 PM		Cole G Bradley (Reporting)
Kiniksa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:27 PM		Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
4:19 PM		Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
05/07/2024
3:46 PM		Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
3:35 PM		Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:36 PM		Kiniksa Pharmaceuticals (Filer)
Form DEF 14A
04/23/2024
3:41 PM		Kiniksa Pharmaceuticals (Filer)
Form ARS
04/23/2024
3:43 PM		Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
04/23/2024
3:46 PM		Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
04/23/2024
6:34 AM		Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
4:00 PM		Kiniksa Pharmaceuticals (Filer)
Form PRE 14A
04/08/2024
4:20 PM		Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:21 PM		Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:22 PM		Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:17 PM		Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:18 PM		Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:19 PM		Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
11:21 AM		BlackRock Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13G/A
04/03/2024
4:22 PM		Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:23 PM		Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:25 PM		Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
6:32 AM		Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
4:00 PM		Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
03/29/2024
6:30 AM		Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
6:30 AM		Kiniksa Pharmaceuticals (Filer)
Form DEFA14A
03/11/2024
6:05 PM		Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:37 PM		Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:24 PM		Kiniksa Pharmaceuticals (Subject)
Patel Sanj K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
5:26 PM		Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:29 PM		Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
4:31 PM		Kiniksa Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
6:35 AM		Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:46 PM		Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2024
5:06 AM		Kiniksa Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G
01/04/2024
6:37 AM		Kiniksa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
3:26 PM		Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:KNSA) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners
Trump’s Secret Manhattan Project
On January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...
Banyan Hill Publishing | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
How this >10-cent coin is going to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
Crypto 101 Media | Sponsored
Seeing is believing…
Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...
Porter & Company | Sponsored
Uncover the Top Gold Stock of the Bull Market
Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?
Huge Alerts | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...
Crypto Swap Profits | Sponsored